BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 335580)

  • 1. The Dalkon Shield, the TCu 200, and the TCu 380A in private practice.
    Thomas WO
    Trans Pac Coast Obstet Gynecol Soc; 1977; 44():78-85. PubMed ID: 335580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term study of the safety of the Dalkon Shield and Gyne-T 200 intrauterine devices.
    Rioux JE; Cloutier D; Dupont P; Lamonde D
    CMAJ; 1986 Apr; 134(7):747-51. PubMed ID: 3948091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twelve-month comparative multicenter study of the TCu 380A and ML 250 intrauterine devices in Bangkok, Thailand.
    Reinprayoon D; Gilmore C; Farr G; Amatya R
    Contraception; 1998 Oct; 58(4):201-6. PubMed ID: 9865999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries.
    Farr G; Amatya R; Acosta M; Ekwempu C; Kisninci H
    Contraception; 1995 Jul; 52(1):17-22. PubMed ID: 8521710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Was the Dalkon Shield a safe and effective intrauterine device? The conflict between case-control and clinical trial study findings.
    Mumford SD; Kessel E
    Fertil Steril; 1992 Jun; 57(6):1151-76. PubMed ID: 1601137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of two techniques used in immediate postplacental insertion of TCu 380A intrauterine device: 12 month follow-up of 910 cases].
    Xu J; Zhuang L; Yu G
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jun; 32(6):354-7. PubMed ID: 9596916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Random comparative study between intrauterine device Multiload Cu375 and TCu 380a inserted in the postpartum period].
    Lara Ricalde R; Menocal Tobías G; Ramos Pérez C; Velázquez Ramírez N
    Ginecol Obstet Mex; 2006 Jun; 74(6):306-11. PubMed ID: 16970116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the delta copper T and the copper T 200 in Bologna, Italy.
    Melega C; Biscontin S; Canedi L; Marchesini FP; Tirelli S; Bartolotti T; Flamigni C
    Acta Eur Fertil; 1986; 17(1):39-41. PubMed ID: 3727892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Randomized comparative study of GyneFix IN and TCu 380A intrauterine devices].
    Wu S; Hu J; Wu M
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jun; 33(6):345-8. PubMed ID: 10806672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type of intrauterine device and the risk of pelvic inflammatory disease.
    Lee NC; Rubin GL; Ory HW; Burkman RT
    Obstet Gynecol; 1983 Jul; 62(1):1-6. PubMed ID: 6856209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between intrauterine contraceptive device use and breast-feeding status at time of intrauterine contraceptive device insertion: analysis of TCu-380A acceptors in developing countries.
    Farr G; Rivera R
    Am J Obstet Gynecol; 1992 Jul; 167(1):144-51. PubMed ID: 1442918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three different models of the copper T intrauterine contraceptive device.
    Roy S; Casagrande J; Cooper DL; Mishell DR
    Am J Obstet Gynecol; 1979 Jul; 134(5):568-74. PubMed ID: 453297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparative study of the copper T 300, Dalkon shield, and Shell Loop in parous women.
    Cooper DL; Israel R; Mishell DR
    Obstet Gynecol; 1975 May; 45(5):569-73. PubMed ID: 1124175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraceptive efficacy of the Copper T 380A and Copper T 200 intrauterine devices: results from a comparative clinical trial in six developing countries.
    Farr G; Amatya R
    Contraception; 1994 Mar; 49(3):231-43. PubMed ID: 8200217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Another look at the Dalkon Shield: meta-analysis underscores its problems.
    Sivin I
    Contraception; 1993 Jul; 48(1):1-12. PubMed ID: 8403900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of age.
    Bahamondes L; Faundes A; Sobreira-Lima B; Lui-Filho JF; Pecci P; Matera S
    Contraception; 2005 Nov; 72(5):337-41. PubMed ID: 16246658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postpartum and postabortal insertion of intrauterine contraceptive devices.
    Martorella LA; Esposito JM
    J Reprod Med; 1975 Apr; 14(4):178-81. PubMed ID: 1142352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IUDs: current perspectives.
    Hepburn S
    Curr Ther (Seaforth); 1994 Oct; 35(10):49-55. PubMed ID: 12319352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of two techniques used in immediate postplacental insertion (IPPI) of the Copper T-380A IUD in Shanghai, People's Republic of China.
    Xu JX; Rivera R; Dunson TR; Zhuang LQ; Yang XL; Ma GT; Chi IC
    Contraception; 1996 Jul; 54(1):33-8. PubMed ID: 8804806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.